Skip To Main Content
Zeynep Ece Kuloğlu on Muck Rack

Zeynep Ece Kuloğlu

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Zeynep Ece

Contact Zeynep Ece, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Viruses | Free Full-Text | BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac

|
By Bircan Kayaaslan, Gülen Esken, Çiğdem Erol, Zeynep Ece Kuloğlu
| MDPI
1. Introduction Since the beginning of the pandemic, the novel coronavirus (SARS-CoV-2) has infected approximately 635 million individuals and caused almost 6.5 million deaths worldwide [1]. Hematopoietic stem cell transplantation (HSCT) and solid organ transplantation (SOT) recipients are at an increased risk for COVID-19 because of immunosuppressive medication and other comorbidities.
Open in Who Shared Issue with article?
See all 1 articles